NIH Licenses New Antibody to Spot Immune Cell Proteins
Published Date: 6/1/2026
Notice
Summary
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Analyzed Economic Effects
6 provisions identified: 4 benefits, 2 costs, 0 mixed.
Antibody 18H2 Available For Licensing
The NIH/NIAID has made monoclonal antibody 18H2 (HHS Ref. No. E-104-2025-0) available for licensing for commercial development under 35 U.S.C. 209 and 37 CFR part 404. If you are a company or research group, you can contact Yogikala Prabhu (tel. 202-365-4785 or [email protected]) to inquire about licensing.
Collaborative Research Opportunities Offered
NIAID is actively seeking statements of capability or interest for collaborative research to further develop, evaluate, or commercialize 18H2, including use in pre-clinical models, diagnostic assay development, and high-throughput screening. Interested parties should contact Yogikala Prabhu at 202-365-4785 or [email protected].
Enables Development of Diagnostic Tests
The 18H2 antibody can be used to develop tests that track regulatory T cell (Treg) function and Eos protein levels in patients to monitor autoimmune diseases, cancer treatments, and organ transplants. Companies and labs could use this technology to build diagnostic assays and immune-monitoring tools.
Technology Is at Pre-Clinical Stage
The 18H2 antibody is described as being at the 'Pre-Clinical' development stage. That means the technology has been validated in laboratory settings but has not yet reached clinical trials or market-ready status.
Confidential Disclosure Agreement Required
A signed Confidential Disclosure Agreement (CDA) is required to receive copies of unpublished information related to the 18H2 invention. Parties must sign the CDA before NIH/NIAID will provide unpublished technical details.
Foreign Patent Filings May Extend Coverage
The notice states that foreign patent applications are filed on selected inventions to extend market coverage and may also be available for licensing. This can affect the geographic scope of licensing rights for 18H2.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10517 — Proposed Collection; 60-Day Comment Request; Data and Specimen Hub (DASH) (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development wants your thoughts on updating their Data and Specimen Hub (DASH), a system that helps researchers share important health data and samples. If you’re involved in health research or data sharing, this affects you! Comments are open until July 27, 2026, and the update aims to make data collection easier without costing extra time or money.
2026-10353 — National Cancer Institute; Notice of Meeting
The National Cancer Institute is holding a virtual meeting on July 15, 2026, to talk about their latest cancer research and clinical trials. Anyone interested can join online, share their thoughts, and learn about new plans that could impact cancer treatment and research funding. This is a great chance for patients, doctors, and researchers to get involved and stay updated!
2026-10310 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting
The National Institute on Deafness and Other Communication Disorders is holding a private virtual meeting on July 20, 2026, to review grant applications. This meeting affects researchers seeking funding for projects related to hearing and communication disorders. No public access is allowed to protect sensitive information, and the decisions could impact future research funding.
2026-10175 — Center for Scientific Review; Notice of Closed Meeting
The Center for Scientific Review is holding a private virtual meeting on June 9, 2026, to review grant applications about infectious diseases and immunology. This closed session protects sensitive info like trade secrets and personal details. Researchers applying for these grants should note the date, as this review impacts funding decisions.
2026-10231 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on June 25, 2026, to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants should note the date, as these reviews impact who gets money for their work.
Previous / Next Documents
Previous: 2026-10811 — National Eye Institute; Notice of Closed Meeting
The National Eye Institute’s advisory council is holding a private virtual meeting on July 17, 2026, to review and decide on grant applications. This meeting affects researchers seeking funding for eye-related projects and keeps sensitive info safe. No money changes are announced yet, but the decisions could impact future research support.
Next: 2026-10814 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in June 2026 to review and evaluate important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.